About bioTheranostics

bioTheranostics, part of the worldwide bioMérieux group, develops molecular diagnostic tests that include supporting the selection of individualized oncology therapies through improved cancer classification and better breast cancer prognosis and recurrence risk stratification. The company operates a CLIA-certified, CAP-accredited diagnostic service laboratory in San Diego, CA.

Defining the need

Cancer is the number two cause of death in the United States, killing 565,650 people annually. Although there has been significant progress in the treatment of cancer over the past 20 years, the overall five-year survival rate is still only 66%.*  Causes for this high mortality rate include late diagnosis, challenging tumor identification and classification, and inappropriate treatment, all of which lead to poorer patient outcomes.

The majority of promising new cancer drugs target selected cancer-activated pathways. To maximize the clinical utility of these new therapies, it is important to both identify and understand the molecular characteristics of each patient’s tumor, and to obtain as much diagnostic and prognostic information as possible for each patient.

Developing the solutions

bioTheranostics is partnered with a network of top-tier clinical and academic leaders who share a vision for the future of cancer diagnostics. These collaborators include researchers from Harvard Medical School/MGH, MD Anderson Cancer Center, Mayo Clinic, Baylor College of Medicine, Sharp Hospital in San Diego, Jules Bordet Institute (Belgium), the Erasmus Medical Center (Rotterdam), and the Sarah Cannon Research Institute.

bioTheranostics has developed molecular-based tests that are objective, quantifiable, practical, and clinically impactful. THEROS CancerTYPE ID® and THEROS Breast Cancer Index℠ are real time RT-PCR based assays compatible with readily available, formalin-fixed paraffin embedded (FFPE) needle core biopsies, excisional biopsies, and surgical samples.

*Source: Cancer Facts & Figures 2008, American Cancer Society